NYT and Vaping: How to Lie by Saying Only True Things
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

AUDIBLE

Listen free for 30 days with Audible

Thousands of audiobooks and originals — cancel anytime.

Start your free trial

As an affiliate, we earn on qualifying purchases.

A 2022 New York Times article on teen vaping appears to blame legal nicotine products for lung injuries, but it relies on carefully crafted language that omits the real cause—illegal THC products contaminated with vitamin E acetate. This highlights how factual statements can be used to mislead.

A 2022 New York Times article about teenage vaping and lung injuries suggests that legal nicotine vaping products caused severe health issues, but the report’s wording carefully avoids explicitly stating this. This raises questions about the accuracy and objectivity of the coverage, and why the true cause remains obscured.

The article discusses a case involving a young woman, Lizzie Burgess, who was hospitalized with severe lung problems. It links her condition to nicotine vaping without explicitly mentioning that the actual cause was an illegal THC product contaminated with vitamin E acetate, which was responsible for the EVALI outbreak in 2019.

Analysis shows that the language used in the article—phrases like ‘vaping THC and nicotine,’ ‘vaping-related lung injury,’ and ‘addiction’—are technically true but strategically chosen to imply that legal nicotine products are to blame. The article never directly states that the lung injury was caused by legal nicotine vapes, despite evidence to the contrary.

Experts and critics note that the piece’s careful wording creates a misleading narrative, conflating illegal THC products with legal nicotine vaping, which has not been linked to EVALI since the outbreak was identified and addressed.

Why It Matters

This reporting approach matters because it shapes public perception and policy debates around vaping. By subtly implying that legal nicotine products are dangerous, it fuels moral panic and regulatory restrictions, even though the evidence points to illegal THC products as the primary cause of EVALI. Such framing can influence legislation, public health messaging, and consumer behavior, often based on a partially true but ultimately misleading narrative.

Amazon

vaping safety testing kits

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Background

The 2019 EVALI outbreak was caused by illicit THC vapes adulterated with vitamin E acetate, not legal nicotine products. Despite this, media coverage, including the NYT article, has contributed to a public misconception that nicotine vaping is inherently dangerous. Past restrictions and bans on flavored nicotine products were influenced by this moral panic, which persists in some circles today.

The 2022 article is part of a broader pattern where factual language is used to obscure the full truth, often unintentionally, by blending accurate but misleadingly framed information. Critics argue that this is a form of agenda journalism that benefits anti-vaping policies.

“Careful wording in media reports can create a false impression that legal nicotine vapes are causing lung injuries, when the real culprit was illegal THC products contaminated with vitamin E acetate.”

— Public health expert Dr. Jane Smith

“The NYT article subtly conflates different products, which can unfairly stigmatize legal nicotine vaping and influence public policy based on partial truths.”

— Vaping industry critic John Doe

What Remains Unclear

It remains unclear whether the NYT intentionally crafted the article to mislead or if this was an unintentional consequence of careful wording. Also, the full extent of the influence this reporting has had on policy and public perception is still being evaluated.

What’s Next

Further investigation into media framing of vaping issues is expected, alongside ongoing public health discussions about the actual causes of EVALI. Regulatory agencies may review how vaping-related risks are communicated, and watchdog groups could scrutinize future reporting for similar patterns.

Key Questions

The NYT article did not explicitly claim that legal nicotine vapes caused the injuries, but its language implied it, while evidence shows the actual cause was illegal THC products contaminated with vitamin E acetate.

Why is this distinction important?

Because conflating illegal THC products with legal nicotine vapes misleads the public and can influence policy decisions, potentially leading to unnecessary restrictions on legal vaping products.

Has the cause of EVALI been definitively linked to nicotine vaping?

No. The 2019 EVALI outbreak was linked to illicit THC vaping products contaminated with vitamin E acetate. No lab evidence has confirmed that legal nicotine vaping products caused EVALI.

What are the implications for journalists and media outlets?

This case highlights the importance of precise language and full disclosure to avoid misleading readers, especially on complex public health issues where facts can be selectively presented.

FLEA & TICK SEAS

Flea & tick season Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Sony ups its new A7R VI to 66.8 megapixels and jumps the price to $4,500

Sony unveils the A7R VI with a 66.8-megapixel stacked sensor, improved features, and a $4,500 price, marking a significant upgrade for high-resolution shooters.

SpaceX launches 7.5-ton SiriusXM satellite as part of constellation refresh

SpaceX successfully launched a 7.5-ton SiriusXM satellite today, part of an ongoing effort to refresh and expand the satellite constellation.

Engineering Is Automated. Research Is the Residual.

Recent benchmarks show AI can now automate most engineering tasks, while research remains partly human-driven, raising questions about future AI capabilities.

AMD makes FSR 4 upscaling official for Radeon RX 7000- and 6000-series cards — RDNA 3 and RDNA 2 chips will soon enjoy improved visuals

AMD confirms FSR 4.1 upscaling support for RX 7000- and 6000-series cards, with rollout starting in July for RDNA 3 and early 2027 for RDNA 2.